Powered by

Advanced Accelerator Applications to Build Targeted Radioligand Therapy Production Facility in Indianapolis; - Site to produce targeted radioligand drugs used in the treatment of cancer

Jun 30, 2020 - PR Newswire

PR Newswire

 Advanced Accelerator Applications S.A.(AAA), a Novartis company, today announced it has executed a sales and purchase agreement for land on which a 50,000 square foot targeted Radioligand Therapy (RLT) manufacturing plant will be built. The new facility will be located within the Purdue Research Park, near the Indianapolis International Airport, with completion and initial operations anticipated in 2023.

The facility will significantly expand AAA's manufacturing ...